Case Reports

Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib

Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Department of Medicine A, University Hospital Münster, Münster
Haematologica Early view Oct 1, 2026 https://doi.org/10.3324/haematol.2026.301553